Harvard Drug Group

Multiple Vitamin Formula

Serving
1 Tablet(s)
Form
tablet
UPC
310267013355
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
2
1 avoid · 1 caution
FDA recalls
6
6 Class I / II
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

9 active ingredients
IngredientAmount% DV
Vitamin A
UNII · 81G40H8B0T
5000 IU100%
Vitamin C
UNII · PQ6CK8PD0R
100 mg167%
Vitamin D3
Vitamin DUNII · 1C6V77QF41
400 IU100%
Thiamine
ThiaminUNII · X66NSO3N35
5 mg333%
Riboflavin
UNII · TLM2976OFR
5 mg294%
Niacinamide
NiacinUNII · 25X51I8RD4
30 mg150%
Vitamin B6
UNII · KV2JZ1BI6Z
2 mg100%
Vitamin B12
UNII · 8406EY2OQA
4 mcg67%
Pantothenic Acid
Pantothenic Acid (Vitamin B5)UNII · 19F5HK2737
10 mg100%
Flagged excipients

2 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Red #40 Lake
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

Recall history

6 FDA recalls

  1. Class II2017-08-02brand-level

    Rugby Tri-vitamin Liquid, 1 2/3 oz (50 mL)

    Reason: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

    FDA record →
  2. Class II2017-08-02brand-level

    Leader Liquid Multivitamin Supplement for Infants and Toddlers , 1 2/3 oz (50 mL)

    Reason: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

    FDA record →
  3. Class II2017-08-02brand-level

    Leader Liquid Vitamin D Supplement for Breastfed Infants, 1 T oz (50 mL)

    Reason: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

    FDA record →
  4. Class II2017-08-02brand-level

    Rugby Liquid Vitamin C Supplement, 4 oz., 118 mL

    Reason: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

    FDA record →
  5. Class II2017-08-02brand-level

    Rugby D 3 Vitamin Liquid, 400 IUI/1 mL, 1 and 2/3 oz., 50 mL

    Reason: The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.

    FDA record →
  6. Class III2014-12-31brand-level

    Thera Tablets with Beta Carotene Dietary Supplement

    Reason: The firm received a complaint that the blister packets were missing labeling information on 12/16/2014, the firm investigated the labeling complaint and found that six 2 x 5 blister cards inside a carton was missing some or all of the product information on the back of the blister card.

    FDA record →
Other ingredients

Dicalcium Phosphate · Microcrystalline Cellulose · Stearic Acid · Magnesium Stearate · Hypromellose · Magnesium Silicate · Polyethylene Glycol · Mineral Oil